Investors

Print
Homepage  >  MEDTOX Info  >  Investors

MEDTOX Scientific, Inc.  Investor Relations 877-715-7236

Basic Industries:  Lab & POC Diagnostic Drug Testing, Clinical Trials, Clinical Toxicology, Lead Screening, Lab Services

NASDAQ Symbol:  MTOX

NASDAQ Fundamentals

MEDTOX Focus:  Building a Business within Laboratory and Diagnostic Testing Markets

LAB DRUG TESTING                 DIAGNOSTIC TESTING                     SPECIALTY LAB TESTING
$500 Million Market*                  Multi-Billion $ Market                         $2 to $2.5 Billion Market*

* MEDTOX estimates


Vital Statistics - Year-End 2007
2007 Revenue: $80.3 Million
2007 EPS: $0.75
Shares Outstanding: 8,434,850
Approximate Public Float: 7,520,000
Insider Ownership: 11%
Institutional Ownership: 59%
Fiscal Year End: December 31

NEWS & INSIGHTS

MEDTOX introduces our new SURE-SCREEN® Dip Device for fast, easy detection of drugs-of-abuse. The new dip format is an easy to use, economical product which is currently designed to be used in the Criminal Justice & Rehabilitation market.


The DOT Publishes Final Rule on Specimen Validity Testing in 49 CFR Part 40.

© 2008 MEDTOX Scientific, Inc. All rights reserved.